Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enxiu Wang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|February 17, 2006
Identification of the segments of the mouse transferrin receptor 1 required for mouse mammary tumor virus infectionEnxiu Wang, Lorraine Albritton, Susan R Ross
Immunotherapy|October 13, 2020
Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapyJie Huang, Liucheng Rong, Enxiu Wang, et al.
The Journal of Cell Biology|August 17, 2011
Aurora B dynamics at centromeres create a diffusion-based phosphorylation gradientEnxiu Wang, Edward R Ballister, Michael A Lampson
Journal of Virology|September 2, 2011
Junin virus infects mouse cells and induces innate immune responsesChristian D Cuevas, Madakasira Lavanya, Enxiu Wang, et al.
Immunology|January 2, 2025
Co-Expression of Dominant-Negative TGF-β Receptor 2 Enhances the Therapeutic Efficacy of Novel TREM1/DAP12-BB-Based CAR-T Cells in Solid TumoursSichao Zhu, Jianping Hu, Jie Lin, et al.
Medical Oncology (Northwood, London, England)|July 5, 2023
A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapyTongpeng Xu, Chen Wang, Xiaoyan Wang, et al.
Biochemical and Biophysical Research Communications|March 5, 2003
Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusionEnxiu Wang, Xiao'ou Sun, Yuan Qian, et al.
Immunotherapy|January 4, 2023
Coexpression of <i>c-Jun</i> in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapyTongpeng Xu, Chen Wang, Xiaomei Chen, et al.
Immunotherapy|July 4, 2019
TREM1/Dap12-based CAR-T cells show potent antitumor activityBing Chen, Min Zhou, Hai Zhang, et al.
Cancer|January 23, 2026
T-cell receptor-like chimeric antigen receptor T cells targeting mesothelin: A first-in-human dose-escalation trial for platinum-resistant advanced ovarian cancerYiyang Shan, Bo Ding, Feng Ji, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|February 17, 2006
Identification of the segments of the mouse transferrin receptor 1 required for mouse mammary tumor virus infectionEnxiu Wang, Lorraine Albritton, Susan R Ross
Immunotherapy|October 13, 2020
Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapyJie Huang, Liucheng Rong, Enxiu Wang, et al.
The Journal of Cell Biology|August 17, 2011
Aurora B dynamics at centromeres create a diffusion-based phosphorylation gradientEnxiu Wang, Edward R Ballister, Michael A Lampson
Journal of Virology|September 2, 2011
Junin virus infects mouse cells and induces innate immune responsesChristian D Cuevas, Madakasira Lavanya, Enxiu Wang, et al.
Immunology|January 2, 2025
Co-Expression of Dominant-Negative TGF-β Receptor 2 Enhances the Therapeutic Efficacy of Novel TREM1/DAP12-BB-Based CAR-T Cells in Solid TumoursSichao Zhu, Jianping Hu, Jie Lin, et al.
Medical Oncology (Northwood, London, England)|July 5, 2023
A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapyTongpeng Xu, Chen Wang, Xiaoyan Wang, et al.
Biochemical and Biophysical Research Communications|March 5, 2003
Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusionEnxiu Wang, Xiao'ou Sun, Yuan Qian, et al.
Immunotherapy|January 4, 2023
Coexpression of <i>c-Jun</i> in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapyTongpeng Xu, Chen Wang, Xiaomei Chen, et al.
Immunotherapy|July 4, 2019
TREM1/Dap12-based CAR-T cells show potent antitumor activityBing Chen, Min Zhou, Hai Zhang, et al.
Cancer|January 23, 2026
T-cell receptor-like chimeric antigen receptor T cells targeting mesothelin: A first-in-human dose-escalation trial for platinum-resistant advanced ovarian cancerYiyang Shan, Bo Ding, Feng Ji, et al.
Pageof 2